Joshua Shinkle Reports New 6.2% Passive Stake in Aditxt, Inc. (ADTX)

On June 17, 2026, Joshua Thomas Shinkle filed a Schedule 13G with the SEC, disclosing a new 6.2% stake in Aditxt, Inc. (ADTX). The filing indicates that Shinkle acquired 50,500 common shares as of the event date on June 11, 2026. This represents a significant increase from a previous holding of zero shares, marking his emergence as a major shareholder. The filing was made under Rule 13d-1(c), which typically applies to passive investors who do not intend to influence or change the control of the issuer. Shinkle maintains sole voting and dispositive power over all 50,500 shares. Aditxt, Inc., a biotech company headquartered in Richmond, Virginia, now counts Shinkle among its primary individual investors. The certification in the document confirms that the securities were acquired in the ordinary course of business and not for the purpose of participating in any transaction aimed at changing the control of the company.